Stryker’s third quarter was marked by broad-based demand and resilient procedural volumes across its business segments, with management highlighting sustained organic sales growth and margin ...

Stryker continues to deliver strong organic growth, having posted organic growth rates of around 10% for a long period of time now. The $4.9 billion Inari Medical acquisition announced this year will ...